TY - JOUR
T1 - Operative choices matter
T2 - the role of UIV and sagittal balance in the development of proximal junctional kyphosis following posterior instrumentation for Scheuermann’s kyphosis
AU - Fano, Adam N.
AU - Matsumoto, Hiroko
AU - Sinha, Rishi
AU - Bonsignore-Opp, Lisa
AU - Boby, Afrain Z.
AU - Roye, Benjamin D.
AU - Iyer, Rajiv
AU - Lenke, Lawrence G.
AU - Luzzi, Andrew
AU - Mizerik, Amber Sentell
AU - Newton, Peter O.
AU - Lonner, Baron
AU - Vitale, Michael G.
N1 - Funding Information:
ANF has no conflicts of interest to disclose. HM has received consulting fees from the Pediatric Spine Study Group, as well as research grants from Pediatric Orthopaedic Society of North America and Scoliosis Research Society. RS has no conflicts of interest to disclose. LB has no conflicts of interest to disclose. AZB has no conflicts of interest to disclose. BDR has received research support from Children’s Spine Foundation, Scoliosis Research Society, Pediatric Orthopaedic Society of North America, Broadwater, Pediatric Orthopaedic Club of New York, OMeGA Medical Grants Association, and Setting Scoliosis Straight Foundation (Harms). RI has no conflicts of interest to disclose. LGL has received personal fees from Medtronic, non-financial support from Broadwater, grants and non-financial support from Scoliosis Research Society, grants from EOS, grants from Setting Scoliosis Straight Foundation, philanthropic support from Evans Family Donation, philanthropic support from Fox Family Foundation, grants and non-financial support from AOSpine, personal fees from Abryx, personal fees from EOS technologies, and personal fees from Acuity Surgical. AL has no conflicts of interest to disclose. ASM has no conflicts of interest to disclose. PON is a board member for Setting Scoliosis Straight Foundation, Rady Children’s Specialists, Scoliosis Research Society, and International Pediatric Orthopedic Think Tank. PON reports grants from Setting Scoliosis Straight Foundation, grants personal fees, and non-financial support from DePuy Synthes Spine, grants and personal fees from Scoliosis Research Society, grants from EOS imaging, personal fees from Thieme Publishing, grants from NuVasive, personal fees from Electrocore, personal fees from Cubist, grants, non-financial support and institutional support from Orthopediatrics, grants, personal fees and non-financial support from Stryker/K2M, grants and non-financial support from Alphatech, grants from Mazor Robotics, personal fees from MiRus, personal fees from Globus Medical, and personal fees from Pacira. PON has a patent Anchoring systems and methods for correcting spinal deformities (8540754) with royalties paid to DePuy Synthes Spine, a patent Low profile spinal tethering systems (8123749) licensed to DePuy Spine, Inc., a patent Screw placement guide (7981117) licensed to DePuy Spine, Inc., a patent Compressor for use in minimally invasive surgery (7189244) licensed to DePuy Spine, Inc., and a patent Posterior spinal fixation pending to K2M. BL has received grants from Depuy Synthes to Setting Scoliosis Straight Foundation in support of the Harms Study Group’s research, personal fees from DePuy synthes, personal fees from Zimmer Biomet, personal fees from ApiFix, personal fees from SpineSearch, personal fees from Paradigm Spine, non-financial support from Setting Scoliosis Straight Foundation. BL is on the editorial board for SRS Spine Deformity Journal. MGV has received grants and personal fees from Biomet, grants and non-financial support from Children’s Spine Foundation, personal fees from East Coast Orthotics and Prosthetics, financial support from Fox, non-financial support from IPOS, grants from OREF, grants and non-financial support from POSNA, non-financial support from Project for Safety in Spine Surgery, grants from OSRF, grants from SRS, personal fees from Stryker, and non-financial support from Wellinks.
Funding Information:
This study was supported in part by grants to the Setting Scoliosis Straight Foundation in support of Harms Study Group research from DePuy Synthes Spine, EOS imaging, Stryker Spine, Medtronic, NuVasive, Zimmer Biomet and the Food and Drug Administration.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Scoliosis Research Society.
PY - 2023
Y1 - 2023
N2 - Purpose: This study sought to investigate associations between upper instrumented vertebra (UIV) location and the risk of proximal junctional kyphosis (PJK) at 2 years following posterior spinal fusion (PSF) for Scheuermann’s kyphosis (SK). Methods: In this retrospective cohort study, SK patients who underwent PSF and reached 2 years postop were identified in a multicenter international registry, excluding those with anterior release, prior spine surgery, neuromuscular comorbidity, post-traumatic kyphosis, or kyphosis apex below T11–T12. Location of UIV as well as the number of levels between UIV and preoperative kyphosis apex was determined. Additionally, the degree of kyphosis correction was evaluated. PJK was defined as a proximal junctional angle ≥ 10° that is ≥ 10° greater than the preoperative measurement. Results: 90 patients (16.5 ± 1.9 yo, 65.6% male) were included. Preoperative and 2-year postoperative major kyphosis was 74.6 ± 11.6° and 45.9 ± 10.5°, respectively. Twenty-two (24.4%) patients developed PJK at 2 years. Patients with UIV below T2 had a 2.09 times increased risk of PJK when compared to those with UIV at or above T2, adjusting for distance between UIV and preoperative kyphosis apex [95% Confidence Interval (CI) 0.94; 4.63, p = 0.070]. Patients with UIV ≤ 4.5 vertebrae from the apex had a 1.57 times increased risk of PJK, adjusting for UIV relative to T2 [95% CI 0.64; 3.87, p = 0.326]. Conclusion: SK patients with UIV below T2 had an increased risk of developing PJK at 2 years following PSF. This association supports consideration of UIV location during preoperative planning. Level of Evidence: Prognostic Level II.
AB - Purpose: This study sought to investigate associations between upper instrumented vertebra (UIV) location and the risk of proximal junctional kyphosis (PJK) at 2 years following posterior spinal fusion (PSF) for Scheuermann’s kyphosis (SK). Methods: In this retrospective cohort study, SK patients who underwent PSF and reached 2 years postop were identified in a multicenter international registry, excluding those with anterior release, prior spine surgery, neuromuscular comorbidity, post-traumatic kyphosis, or kyphosis apex below T11–T12. Location of UIV as well as the number of levels between UIV and preoperative kyphosis apex was determined. Additionally, the degree of kyphosis correction was evaluated. PJK was defined as a proximal junctional angle ≥ 10° that is ≥ 10° greater than the preoperative measurement. Results: 90 patients (16.5 ± 1.9 yo, 65.6% male) were included. Preoperative and 2-year postoperative major kyphosis was 74.6 ± 11.6° and 45.9 ± 10.5°, respectively. Twenty-two (24.4%) patients developed PJK at 2 years. Patients with UIV below T2 had a 2.09 times increased risk of PJK when compared to those with UIV at or above T2, adjusting for distance between UIV and preoperative kyphosis apex [95% Confidence Interval (CI) 0.94; 4.63, p = 0.070]. Patients with UIV ≤ 4.5 vertebrae from the apex had a 1.57 times increased risk of PJK, adjusting for UIV relative to T2 [95% CI 0.64; 3.87, p = 0.326]. Conclusion: SK patients with UIV below T2 had an increased risk of developing PJK at 2 years following PSF. This association supports consideration of UIV location during preoperative planning. Level of Evidence: Prognostic Level II.
KW - Kyphosis apex
KW - Pelvic incidence (PI)
KW - Posterior spinal fusion (PSF)
KW - Proximal junctional kyphosis (PJK)
KW - Scheuermann’s kyphosis (SK)
KW - Upper instrumented vertebra (UIV)
UR - http://www.scopus.com/inward/record.url?scp=85149388109&partnerID=8YFLogxK
U2 - 10.1007/s43390-023-00666-1
DO - 10.1007/s43390-023-00666-1
M3 - Article
AN - SCOPUS:85149388109
SN - 2212-134X
JO - Spine Deformity
JF - Spine Deformity
ER -